Back
BioCorRx, Inc. 10K Form
Sell
33
BICX
BioCorRx, Inc.
Last Price:
$0.31
Seasonality Move:
5.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-14 | 10Q | BICX/BioCorRx, Inc. Quarterly |
| 2020-05-15 | 10Q | BICX/BioCorRx, Inc. Quarterly |
| 2020-03-30 | 10K | BICX/BioCorRx, Inc. Annual |
| 2019-11-14 | 10Q | BICX/BioCorRx, Inc. Quarterly |
| 2019-08-14 | 10Q | BICX/BioCorRx, Inc. Quarterly |
| 2019-05-15 | 10Q | BICX/BioCorRx, Inc. Quarterly |
Receive BICX News And Ratings
See the #1 stock for the next 7 days that we like better than BICX
BICX Financial Statistics
Sales & Book Value
| Annual Sales: | $7.7K |
|---|---|
| Cash Flow: | $-634.4K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.67 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.32140 |
|---|---|
| Net Income (TTM): | $-4.3M |
| Gross Margin: | $-89.3K |
| Return on Equity: | 0% |
| Return on Assets: | -96.74% |
BioCorRx, Inc. Earnings Forecast
Key BioCorRx, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for BICX is -1,159.74%.
-
The Selling, General & Administrative Expenses for BICX have been equal to 46,915.58% of Gross Profit Margin.
-
The Research & Development expenses have been 19,258.44% of Revenue.
-
The Net Earning history of BICX is -67,689.61% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 6 years.
BioCorRx, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | BICX |
| Website: | biocorrx.com |
Debt
| Debt-to-Equity Ratio: | -0.58 |
|---|---|
| Current Ratio: | 0.1 |
| Quick Ratio: | 0.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BICX Technical Analysis vs Fundamental Analysis
Sell
33
BioCorRx, Inc. (BICX)
is a Sell
Is BioCorRx, Inc. a Buy or a Sell?
-
BioCorRx, Inc. stock is rated a SellThe current BioCorRx, Inc. [BICX] share price is $0.31. The Score for BICX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.